Capital Fund Management S.A. Abb Vie Inc. Transaction History

Capital Fund Management S.A.

$34.4 Billion
Q1 2024

A detailed history of Capital Fund Management S.A. transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital Fund Management S.A. holds 392,200 shares of ABBV stock, worth $67.3 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

392,200

Previous 276,712 41.74%

Holding current value

$67.3 Million

Previous $42.9 Million 66.55%

% of portfolio

0.21%

Previous 0.12%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $60.9 Million - $68.6 Million	-442,483 Reduced 61.52%	276,712 $42.9 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $51.4 Million - $59.5 Million	385,016 Added 115.21%	719,195 $107 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $44.3 Million - $55.1 Million	334,179 New	334,179 $45 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $2.66 Million - $3.19 Million	-19,234 Reduced 12.99%	128,808 $20.8 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $19.9 Million - $22.8 Million	148,042 New	148,042 $19.9 Billion

Q4 2021 Feb 10, 2022	SELL	$107.43 - $135.93 $7.73 Million - $9.78 Million	-71,951 Reduced 45.09%	87,617 $11.9 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $568,920 - $645,810	5,347 Added 3.47%	159,568 $17.2 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $6.84 Million - $7.62 Million	64,973 Added 72.8%	154,221 $17.4 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $4.46 Million - $4.91 Million	43,574 Added 95.4%	89,248 $9.66 Million
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $31.7 Million - $42.5 Million	-432,538 Reduced 90.45%	45,674 $4.48 Million
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $22.4 Million - $34 Million	347,634 Added 266.23%	478,212 $36.4 Million
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $28.9 Million - $36.2 Million	-400,618 Reduced 75.42%	130,578 $11.6 Million
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $6.3 Million - $7.57 Million	-100,000 Reduced 15.84%	531,196 $40.2 Million
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $4.39 Million - $5.61 Million	66,800 Added 11.84%	631,196 $45.9 Million
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $41.3 Million - $48.7 Million	535,969 Added 1885.42%	564,396 $45.5 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $112 Million - $138 Million	-1,439,785 Reduced 98.06%	28,427 $2.62 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $17.8 Million - $19.8 Million	200,000 Added 15.77%	1,468,212 $139 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $78.4 Million - $92.7 Million	873,100 Added 220.98%	1,268,212 $118 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $36.4 Million - $48.7 Million	395,112 New	395,112 $37.4 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account

Capital Fund Management S.A. Abb Vie Inc. Transaction History